News

Clarivate and Relatable Healthcare Revolutionize Medtech Sales

Clarivate and Relatable Healthcare Revolutionize Medtech Sales

Clarivate and Relatable Healthcare Form Strategic Alliance

Clarivate Plc (NYSE: CLVT) has announced an exciting new partnership with Relatable Healthcare, aiming to transform the medtech sector. Together, they plan to streamline the sales contracting process for medical device makers and distributors, boosting efficiency and competitiveness in the industry.

The Strength of Relatable™ PRM Platform

At the center of this partnership is the Relatable™ Product Relationship Management (PRM) platform. This cutting-edge tool is tailored specifically for medtech companies. It acts as an essential resource, delivering a comprehensive source of vital product information and competitor insights. By using this platform, sales, contracting, and marketing teams can operate more efficiently, paving the way for cost-effective revenue growth.

Integrating Competitive Intelligence

This collaboration with Clarivate provides users of the Relatable™ platform with detailed market intelligence that their teams can strategically leverage. This includes key product specifications, inventory levels, sales materials, and insights into market trends as well as compliance data. With this extensive information, teams can develop informed pricing strategies and improve contract compliance.

Leadership Insights

Andrew Lee, Vice President of Medtech, Life Sciences & Healthcare at Clarivate, shares that the goal of this partnership is to enhance market intelligence for their clients. "By expanding our data analytics offerings, we aim to speed up our clients' growth in the medical device sector," he noted. He envisions this collaboration as a means to facilitate quicker access to essential medical products for patients.

In a similar vein, Joshua Emert, CEO of Relatable Healthcare, underscores the significance of intuitive software solutions. He believes their innovative approach can help medical device firms modernize workflows across various departments. Emert emphasized that this partnership strengthens their ability to adapt to competitive pressures in the market.

Navigating a Challenging Landscape

The ever-changing healthcare landscape brings unique challenges for medtech companies. These organizations feel constant pressure to effectively communicate the value of their products while navigating a dynamic market. As healthcare providers tighten their budgets, the necessity for accurate and timely competitive intelligence becomes increasingly important.

This collaboration presents a solution, offering medtech organizations improved visibility into the market. By merging Clarivate's insights with Relatable's software capabilities, these companies gain the tools they need to confidently present their offerings and respond to requests for proposals more effectively.

Streamlining Commercialization Processes

This strategic partnership empowers medical device companies to better serve Integrated Delivery Networks (IDNs), Group Purchasing Organizations (GPOs), health systems, hospitals, and clinics. With enhanced data management and insights, vendors can simplify commercialization processes and seize new business opportunities.

The combined strengths of Clarivate and Relatable create a dynamic synergy that supports medtech organizations in achieving contract compliance and allows them to compete effectively in this fast-paced environment. In essence, this collaboration is set to revolutionize how medical device companies approach their sales and contracting processes.

About Clarivate

Clarivate™ is a well-respected global provider of transformative intelligence, offering enriched data, insights, and analytics across multiple sectors, including life sciences and healthcare.

About Relatable Healthcare

Relatable Healthcare focuses on innovative Product Relationship Management solutions tailored for the medical device industry, enhancing revenue efficiency through effective processes.

Frequently Asked Questions

What is the main goal of the partnership between Clarivate and Relatable Healthcare?

The partnership's primary goal is to streamline the sales contracting process for medical device companies, boosting their efficiency and competitiveness in the market.

How does the Relatable™ platform support medtech companies?

The Relatable™ platform serves as a comprehensive data management tool, offering critical insights into product specifications, competitive intelligence, and compliance tracking.

Who are the primary leaders in this collaboration?

Andrew Lee, the VP of Medtech at Clarivate, and Joshua Emert, the CEO of Relatable Healthcare, are the key figures advocating for this partnership.

What challenges do medtech companies face today?

Medtech companies struggle with the need to effectively communicate the value of their products while managing tight budgets and adapting to the changing needs of healthcare providers.

How does this partnership benefit healthcare providers?

Healthcare providers gain improved visibility into competitive offerings, allowing them to make better-informed purchasing decisions and enhance product selections in a budget-constrained environment.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Cipher Mining's March 2025 Progress Report for Investors

Updated Category News Views 181

Cipher Mining's Operational Highlights for March 2025 CIPHER MINING INC. (NASDAQ:CIFR) has recently shared its operational update reflecting the ongoing growth and efficiency achieved in March 2025. This report showcases significant advancements in bitcoin production and the strategic development of infrastructure. Key Operational Metrics The report reveals some...

Continue Reading
Understanding the Recent Gains of Monolithic Power Systems (MPWR)

Updated Category News Views 167

Monolithic Power Systems (MPWR) Overview Monolithic Power Systems, Inc. (NASDAQ: MPWR) has made significant strides recently, noted particularly for its notable Power Inflow. For those involved in trading, particularly with a focus on institutional movement and order flow analytics, this development is crucial. What is Power Inflow? The term 'Power Inflow' relates to the...

Continue Reading
Unveiling Growth: Contract Manufacturing and Design Services

Updated Category News Views 167

Contract Manufacturing and Design Services Market Overview The Contract Manufacturing and Design Services (CMDS) market is rapidly evolving, with projections indicating a remarkable growth trajectory. As businesses pivot towards outsourcing production and design, the market size is expected to escalate from USD 621.36 billion to an impressive USD 1441.89 billion by 2032,...

Continue Reading
Understanding Solana's Dynamic Moves Amid Market Pressures

Updated Category News Views 270

Solana's Market Status and Current Challenges Solana (CRYPTO: SOL) is currently facing intense market pressure as it tests the critical $186 support level. With nearly $400 million in cumulative outflows recently observed, the future direction of this cryptocurrency is under close scrutiny. The sell-off occurs at a particularly crucial time, placing Solana's stability at...

Continue Reading
Leadership Changes at Ashford Inc. to Drive Future Growth

Updated Category News Views 224

Leadership Changes at Ashford Inc. Ashford Inc. has made significant strides in enhancing its executive team with the recent appointments of Hector Sanchez as president and Eric Batis as chief operating officer. This strategic move is aimed at reinforcing the company's commitment to long-term growth and operational excellence. Insights on Hector Sanchez's New Role In his...

Continue Reading